Idiopathic pulmonary fibrosis: FDA approves nintedanib (Ofev) FARMACOLOGIA HEALTH U.S. MALATTIE RESPIRATORIE Idiopathic pulmonary fibrosis: FDA approves nintedanib (Ofev) Redazione 18 Ottobre 2014 The U.S. Food and Drug Administration approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF). Per saperne di piรน Maggiori informazioni su Idiopathic pulmonary fibrosis: FDA approves nintedanib (Ofev)